Published October 2003 | Version v1
Journal article

Changes of serum E-CAd and SF levels in patients with primary hepatic cancer after intervention therapy

Creators

  • 1. Lianyungang Second People's Hospital, Lianyungang (China)

Description

Objective: To investigate the changes of serum E-CAd and SF levels in 33 patients with primary hepatic cancer after intervention therapy. Methods: Serum SF levels were determined with RIA and serum E-CAd levels with ELISA in 33 patients and 35 controls. Results: Before intervention therapy, serum SF and E-CAd levels were significantly higher in the patients than those in controls (p<0.01). Twenty-two of the 30 patients underwent intervention therapy showed no sign of recurrence at 6 months and their serum SF and E-CAd levels dropped to within normal range. However, in the 8 patients with recurrence, serum levels of SF and E-CAd remained abnormally high. Conclusion: Serum SF, E-CAd levels were closely related to the disease process of primary hepatic cancer and were of prognostic value

Additional details

Publishing Information

Journal Title
Journal of Radioimmunology
Journal Volume
16
Journal Issue
5
Journal Page Range
p. 263-264
ISSN
1008-9810